ANNUAL REPORT 2025
The European Medicines Agency’s contribution to science, medicines and health in 2025.
Scroll down to explore the digital report Download PDF version
Chapter 1
Key achievements in 2025
The first chapter highlights EMA’s strategic priorities and key contributions to protecting public and animal health across Europe. Explore the links below to discover the most significant milestones in the evaluation and supervision of human and veterinary medicines, along with major achievements throughout 2025.
- Evaluation and monitoring of medicines: highlights
- 30 years of progress in science and medicines in the European Union
- Accelerating and optimising the assessment of medicines
- Facilitating the path to accessibility and strengthening the availability of medicines
- Enhancing the sustainability of the network
Key activities and events in 2025
Read timeline
EMA by numbers
Key figures on EMA's recommendationsfor the authorisation of new medicines in 2025:
0
positive opinions for human medicines
0
human medicines with a new active substance
0
negative opinions for human medicines
0
positive opinions for veterinary medicines
0
veterinary medicines with a new active substance
0
negative opinions for veterinary medicines
Chapter 2
Key figures in 2025
The second chapter presents a selection of key figures and trends illustrating EMA’s activities in the regulation of medicines in the EU. Click on the links below to explore the core statistics from 2025.
